Last Chance: Get 30 Days of MarketBeat All Access for FREE, then just $399 $199 for the year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
EXTENDED - TODAY ONLY: MarketBeat All Access For Just $399 $199 (save 50%)
×
S&P 500   3,963.94
DOW   33,849.46
QQQ   282.71
Wall Street slips as lockdown protests spread in China
Why is Russia reopening dormant copper mines? (Ad)
China virus protests hit Hong Kong after mainland rallies
Is Snowflake Poised for A Rebound After Its Recent Tumble?
This Govt. Act Can Help Investors (Ad)
Need To Cut Costs? Start With These 10 Money Saving Ideas
Check Into The Hotel Rebound With These Welcoming Stocks
This Govt. Act Can Help Investors (Ad)
Impeachment talk at Trump Org. trial: Did witness misspeak?
'Gaslighting' is Merriam-Webster's word of the year for 2022
S&P 500   3,963.94
DOW   33,849.46
QQQ   282.71
Wall Street slips as lockdown protests spread in China
Why is Russia reopening dormant copper mines? (Ad)
China virus protests hit Hong Kong after mainland rallies
Is Snowflake Poised for A Rebound After Its Recent Tumble?
This Govt. Act Can Help Investors (Ad)
Need To Cut Costs? Start With These 10 Money Saving Ideas
Check Into The Hotel Rebound With These Welcoming Stocks
This Govt. Act Can Help Investors (Ad)
Impeachment talk at Trump Org. trial: Did witness misspeak?
'Gaslighting' is Merriam-Webster's word of the year for 2022
S&P 500   3,963.94
DOW   33,849.46
QQQ   282.71
Wall Street slips as lockdown protests spread in China
Why is Russia reopening dormant copper mines? (Ad)
China virus protests hit Hong Kong after mainland rallies
Is Snowflake Poised for A Rebound After Its Recent Tumble?
This Govt. Act Can Help Investors (Ad)
Need To Cut Costs? Start With These 10 Money Saving Ideas
Check Into The Hotel Rebound With These Welcoming Stocks
This Govt. Act Can Help Investors (Ad)
Impeachment talk at Trump Org. trial: Did witness misspeak?
'Gaslighting' is Merriam-Webster's word of the year for 2022
S&P 500   3,963.94
DOW   33,849.46
QQQ   282.71
Wall Street slips as lockdown protests spread in China
Why is Russia reopening dormant copper mines? (Ad)
China virus protests hit Hong Kong after mainland rallies
Is Snowflake Poised for A Rebound After Its Recent Tumble?
This Govt. Act Can Help Investors (Ad)
Need To Cut Costs? Start With These 10 Money Saving Ideas
Check Into The Hotel Rebound With These Welcoming Stocks
This Govt. Act Can Help Investors (Ad)
Impeachment talk at Trump Org. trial: Did witness misspeak?
'Gaslighting' is Merriam-Webster's word of the year for 2022
NASDAQ:ACRS

Aclaris Therapeutics - ACRS SEC Filings & 10K Form

$16.99
-0.54 (-3.08%)
(As of 11/28/2022 12:00 AM ET)
Add
Compare
Today's Range
$16.85
$17.68
50-Day Range
$13.07
$18.37
52-Week Range
$9.26
$18.96
Volume
195,970 shs
Average Volume
322,995 shs
Market Capitalization
$1.13 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$36.00

Recent Aclaris Therapeutics SEC Filings

DateFilerForm TypeView
11/22/2022
3:12 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2022
3:51 PM
Aclaris Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2022
6:30 AM
Aclaris Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2022
6:15 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/26/2022
6:09 PM
Aclaris Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/19/2022
3:49 PM
Aclaris Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/19/2022
3:45 PM
Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2022
3:35 PM
Aclaris Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2022
4:58 PM
Aclaris Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2022
6:30 AM
Aclaris Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/03/2022
6:15 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2022
4:10 PM
Aclaris Therapeutics (Issuer)
Manion Douglas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2022
4:06 PM
Aclaris Therapeutics (Issuer)
Manion Douglas J. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/01/2022
3:45 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2022
3:45 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2022
4:01 PM
Aclaris Therapeutics (Issuer)
Cawkwell Gail (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2022
3:54 PM
Aclaris Therapeutics (Issuer)
Cawkwell Gail (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/06/2022
4:36 PM
Aclaris Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2022
4:33 PM
Aclaris Therapeutics (Issuer)
Reasons Bryan M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2022
4:30 PM
Aclaris Therapeutics (Issuer)
Powell Andrew Kenneth William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2022
4:27 PM
Aclaris Therapeutics (Issuer)
Molineaux Christopher P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2022
4:24 PM
Aclaris Therapeutics (Issuer)
MILANO VINCENT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2022
4:21 PM
Aclaris Therapeutics (Issuer)
Mehra Anand (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2022
4:18 PM
Aclaris Therapeutics (Issuer)
Humphries William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2022
4:15 PM
Aclaris Therapeutics (Issuer)
GOWEN MAXINE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2022
4:15 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2022
7:01 AM
Aclaris Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/10/2022
7:01 AM
Aclaris Therapeutics (Filer)
Aclaris Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/10/2022
6:30 AM
Aclaris Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2022
6:15 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2022
4:13 PM
Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2022
3:30 PM
Aclaris Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G
04/21/2022
6:03 AM
Aclaris Therapeutics (Filer)
Form DEFA14A
04/21/2022
6:01 AM
Aclaris Therapeutics (Filer)
Form DEF 14A
04/20/2022
4:06 PM
Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/13/2022
8:36 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/02/2021
4:39 PM
Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2021
3:01 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2021
6:31 AM
Aclaris Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2021
6:15 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2021
4:32 PM
Aclaris Therapeutics (Issuer)
Gordon David N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2021
5:03 PM
Aclaris Therapeutics (Issuer)
Gordon David N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2021
3:01 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2021
3:26 PM
Aclaris Therapeutics (Filer)
Form 424B5
06/08/2021
3:25 PM
Aclaris Therapeutics (Filer)
Form 424B5
06/08/2021
6:16 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2021
7:12 PM
Aclaris Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2021
7:09 PM
Aclaris Therapeutics (Issuer)
Reasons Bryan M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2021
7:07 PM
Aclaris Therapeutics (Issuer)
Powell Andrew Kenneth William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2021
7:05 PM
Aclaris Therapeutics (Issuer)
Molineaux Christopher P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2021
7:02 PM
Aclaris Therapeutics (Issuer)
MILANO VINCENT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2021
7:00 PM
Aclaris Therapeutics (Issuer)
Mehra Anand (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2021
6:57 PM
Aclaris Therapeutics (Issuer)
Humphries William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2021
6:55 PM
Aclaris Therapeutics (Issuer)
GOWEN MAXINE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2021
6:52 PM
Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2021
4:02 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2021
8:49 PM
Aclaris Therapeutics (Issuer)
Gordon David N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2021
8:47 PM
Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2021
8:45 PM
Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2021
8:43 PM
Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2021
8:41 PM
Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2021
3:17 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2021
5:06 PM
Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/07/2021
5:28 PM
Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2021
3:45 PM
Aclaris Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/07/2021
6:30 AM
Aclaris Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2021
6:15 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2021
7:04 PM
Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2021
8:45 PM
Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2021
8:43 PM
Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2021
6:03 AM
Aclaris Therapeutics (Filer)
Form DEFA14A
04/22/2021
6:00 AM
Aclaris Therapeutics (Filer)
Form DEF 14A
03/03/2021
7:42 PM
Aclaris Therapeutics (Issuer)
Gordon David N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:39 PM
Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:36 PM
Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:32 PM
Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
6:33 AM
Aclaris Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2021
6:15 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2021
1:56 PM
Aclaris Therapeutics (Subject)
Foresite Capital Fund III, L.P. (Filed by)
Form SC 13G/A
02/11/2021
6:29 AM
Aclaris Therapeutics (Subject)
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Form SC 13G/A
02/10/2021
5:00 PM
Aclaris Therapeutics (Issuer)
Foresite Capital Fund III, L.P. (Reporting)
Foresite Capital Fund IV, L.P. (Reporting)
Foresite Capital Fund V, L.P. (Reporting)
Foresite Capital Management III, LLC (Reporting)
Foresite Capital Management IV, LLC (Reporting)
Foresite Capital Management V, LLC (Reporting)
Tananbaum James B. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/03/2021
4:33 PM
Aclaris Therapeutics (Issuer)
Mehra Anand (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
4:29 PM
Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
4:26 PM
Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
4:23 PM
Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2021
7:45 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/20/2021
4:00 PM
Aclaris Therapeutics (Filer)
Form 424B5
01/20/2021
6:18 AM
Aclaris Therapeutics (Filer)
Form S-3MEF
01/19/2021
3:04 PM
Aclaris Therapeutics (Filer)
Form 424B5
12/17/2020
4:08 PM
Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
4:07 PM
Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
4:06 PM
Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2020
6:16 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2020
6:32 AM
Aclaris Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2020
6:15 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/26/2020
3:49 PM
Aclaris Therapeutics (Subject)
Aclaris Therapeutics (Subject)
Rock Springs Capital Management LP (Filed by)
Form SC 13G
09/15/2020
6:05 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2020
3:23 PM
Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2020
4:18 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2020
4:28 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page (NASDAQ:ACRS) was last updated on 11/29/2022 by MarketBeat.com Staff